Arrowpoint Investment Partners »

Axsome Therapeutics shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $385k 2.1k 182.64

More positions owned by Arrowpoint Investment Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Home Depot (HD)
Qualcomm (QCOM)
Palantir Technologies Cl A (PLTR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
Apple (AAPL)
Aegon Amer Reg 1 Cert (AEG)
Tesla Motors (TSLA)
Paypal Holdings (PYPL)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Eli Lilly & Co. (LLY)

View all positions for Arrowpoint Investment Partners

Top funds holding Axsome Therapeutics

Vanguard Group
BlackRock
Wellington Management Company
Invesco
Deep Track Capital
Geode Capital Management
State Street Corporation
FMR
Rtw Investments
Alethea Capital Management
Susquehanna International
Eventide Asset Management
Partner Fund Management
Norges Bank Investment Management
BVF

View all funds holding Axsome Therapeutics